Citius Oncology (CTOR) Notes Payables (2023 - 2026)

Citius Oncology's Notes Payables history runs 4 years deep, the most recent figure standing at $3.8 million for Q1 2026.

• In Q1 2026, Notes Payables changed 0.0% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $3.8 million (changed 0.0% YoY), while the FY2025 annual figure was $3.8 million, changed 0.0% from the prior year.
• Notes Payables was $3.8 million for Q1 2026 at Citius Oncology, roughly flat from $3.8 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $3.8 million in Q3 2024 to a low of $1.3 million in Q4 2023.
• Historically, Notes Payables has averaged $3.1 million across 4 years, with a median of $3.8 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Notes Payables surged 187.89% in 2024, then changed 0.0% in 2025.
• A 4-year view of Notes Payables shows it stood at $1.3 million in 2023, then soared by 187.89% to $3.8 million in 2024, then changed by 0.0% to $3.8 million in 2025, then changed by 0.0% to $3.8 million in 2026.
• The last three Notes Payables figures came in at $3.8 million (Q1 2026), $3.8 million (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.